Can BIGTINCAN make it BIG?, page-17

I’ve finished buying on market over the past few trading session, lucky to time it with today’s excellent rise. It seems we have a real business on the ASX.

There is an easy 200%+ to be made holding this through 2018. I sold GSW too early and won’t be making the same mistake. Revenues for BTH are growing at a nice pace with blue chip clients. A low attrition rate means the product is very sticky. I was impressed to see Abiomed and Cyrolife signing deals and the recent Verizon deal will only open up further collaborations.

The technology business model has just been proven with cashflow ticking over positive. Our CEO is the leading shareholder and on the same page.

The 4Cs will be anticipated, management are too busy establishing a global footprint instead of spruiking the stock. The numbers will do the talking.

Great notes by @CanadianDream - A great Xmas gift to be buying a notch above its IPO price earlier this year.